Indexed metadata
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria
Sabine Altrichter, Petra Staubach, Malika Pasha, Bhupinder Singh, Alan T. Chang, Jonathan A. Bernstein, Henrik S. Rasmussen, Frank Siebenhaar, Marcus Maurer
Source record
Source: Crossref
Published: May 1, 2022
DOI: 10.1016/j.jaci.2021.12.772
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.